Future research should focus on establishing clinically relevant thresholds, optimizing KIM-1-based prediction models for diverse populations, and incorporating KIM-1 into multi-biomarker panels to enhance kidney disease diagnostics and risk assessment. Here, HAVCR1 is linked to kidney disorder.